Today, industrials editor and analyst Brendan Byrnes discusses Brazil and its recently hot auto sales. Sales in July jumped 22% -- the country's best July ever for vehicle sales. Most of this increase was driven by a government stimulus program that began in May, including industrial tax breaks on some vehicles and better terms for loans. But what happens when these tax incentives expire in August? It may be a case of bad timing for Ford, which made only $5 million in South America last quarter and is relying on several new vehicles being released in the second half of 2012 to drive sales. Check out the video below for more on Ford in South America, and what we can expect from the automaker there.
Ford has been performing very well as a company over the past few years -- it's making good vehicles, is consistently profitable, recently reinstated its , and has done a remarkable job paying down its . But Ford's price is down more than 13% year-to-date. Does this create an incredible buying opportunity, or are there hidden risks with the stock that investors need to know about? To answer that, one of our top equity analysts has compiled a premium research report with in-depth analysis on right now, and why. Simply to get instant access to this premium report.
Brendan Byrnes owns shares of Ford. The Motley Fool owns shares of Ford. Motley Fool newsletter services recommend Ford. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
What Happened in the Stock Market Today
Stocks had a huge day, sending the major indexes to new records. Shares of Juno Therapeutics soared following a buyout report, and Ford slumped on disappointing guidance.
Why Shares of Ford Motor Company Fell 7% Today
Ford's 2018 guidance didn't sit well with investors.
Ford's Behind-the-Scenes Focus on Data
Ford’s recent partnerships and small-scale tests could bode well for the future.